Pages that link to "Q26796451"
Jump to navigation
Jump to search
The following pages link to Translational challenges of animal models in Chagas disease drug development: a review (Q26796451):
Displaying 25 items.
- Chagas disease (Q649558) (← links)
- Neglected tropical diseases in the genomics era: re-evaluating the impact of new drugs and mass drug administration (Q28602660) (← links)
- Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria. (Q33743694) (← links)
- Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease (Q36287327) (← links)
- Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi (Q36571788) (← links)
- Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage (Q37342932) (← links)
- Chagas disease research and development: Is there light at the end of the tunnel? (Q37541623) (← links)
- Status of vaccine research and development of vaccines for Chagas disease (Q38898612) (← links)
- Putting Infection Dynamics at the Heart of Chagas Disease (Q38950397) (← links)
- A multi-parametric analysis of Trypanosoma cruzi infection: common pathophysiologic patterns beyond extreme heterogeneity of host responses. (Q40085004) (← links)
- Use of Noninvasive Parameters to Evaluate Swiss Webster Mice During Trypanosoma cruzi Experimental Acute Infection (Q40841680) (← links)
- The Trypanocidal Effect of Novel Quinolines: In vitro And In vivo Studies (Q46248416) (← links)
- A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging. (Q52577966) (← links)
- Chagas disease (Q56794453) (← links)
- Repurposing Strategy of Atorvastatin against Trypanosoma cruzi: Monotherapy and Combined Therapy with Benznidazole Exhibit Synergistic Trypanocidal Activity (Q57167324) (← links)
- Experimental combination therapy using low doses of benznidazole and allopurinol in mouse models of Trypanosoma cruzi chronic infection (Q57285891) (← links)
- Relevance of Trypanothione Reductase Inhibitors on Trypanosoma cruzi Infection: A Systematic Review, Meta-Analysis, and In Silico Integrated Approach (Q58865487) (← links)
- An Animal Model of Acute and Chronic Chagas Disease With the Reticulotropic Y Strain of That Depicts the Multifunctionality and Dysfunctionality of T Cells (Q64084883) (← links)
- Impact of autologous whole blood administration upon experimental mouse models of acute Trypanosoma cruzi infection. (Q64947394) (← links)
- Autophagy plays a protective role against Trypanosoma cruzi infection in mice (Q92094072) (← links)
- Infection by Trypanosoma cruzi in the central nervous system in non-human mammals: a systematic review (Q92380473) (← links)
- Advances in preclinical approaches to Chagas disease drug discovery (Q92610556) (← links)
- Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains (Q92711796) (← links)
- Wikidata:Database reports/Constraint violations/P275 (← links | edit)
- Wikidata:Database reports/Constraint violations/P2860 (← links | edit)